Saturday, August 29, 2026

Unlock the Future: A Comprehensive Guide to Meta’s AI Glasses and Their Amazing Capabilities

Meta launched AI glasses in Korea, enabling hands-free interaction with an AI assistant for real-time information and translation.

Samsung Bioepis Launches SBE303: The First ADC Drug Candidate Targeting Nectin-4 in Cancer Trials

Samsung Bioepis has begun Phase 1 trials for its ADC candidate SBE303, targeting solid tumors, set to continue until July 2030.

North Korea Lifts Warship After Embarrassing Launch Flop

North Korea's 5,000-ton destroyer is upright after capsizing during launch, with repairs likely needed for its bow-mounted sonar system.

Tag: SCD0503

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.